lungs Related Content
Supporting the addition of asthma medications to the exemption list in the UK
Dr Fred A. Wagshul, Pulmonologist and Medical Director at the Lung Center of America explains why he supports the addition of asthma medications to the exemption list in the UK.
Why is respiratory protection so important?
Paul Riddick, Co-Founder and Technical Director at Vodex explores how contaminates being produced on a daily basis in the workplace can damage your health and could even prove fatal.
Malaria Consortium calls for greater action and innovation to combat pneumonia
On this year’s World Pneumonia Day, Malaria Consortium is calling on the international community to increase its support for innovation as it tackles the world’s biggest infectious killer of children under the age of 5
Dyspnoea (breathlessness): Still an ongoing battle
Katy Beckford and Alex Christie from the Association of Respiratory Nurse Specialists detail precisely why dyspnoea (breathlessness) remains an ongoing battle today
The need to improve the diagnosis of chronic inflammatory lung diseases
Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
An introduction to shortness of breath (dyspnoea)
NHS 24 provides an introduction to sudden shortness of breath, which is also known as breathing difficulty (dyspnoea)
New discovery for the treatment of Pulmonary Arterial Hypertension
Revolutionary discovery brings hope to lung disease sufferers after scientists from Université Paris-Saclay find a way to stop the deterioration of the arteries
Technology interventions to address dyspnoea: Point-of-care lung ultrasonography
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography
The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...
Distinct ARDS morphotypes based on lung imaging patterns
Matthieu JABAUDON from Université Clermont Auvergne unveils his thoughts on distinct acute respiratory distress syndrome (ARDS) morphotypes based on lung imaging patterns
It has long been recognised that acute respiratory distress syndrome (ARDS) is a clinical syndrome with marked heterogeneity in its presentation and clinical course (see www.openaccessgovernment.org/acute-respiratory-distress-syndrome-2/34971).
One approach to...
Pneumology & Pulmonary Cell Research
Prof Dr Michael Roth (PhD) at University Hospital Basel looks at pneumology & pulmonary cell research, in this profile of the organisation's research
New biomarkers of lung injury in ARDS
Associate professor at CHU Clermont-Ferrand, Université Clermont Auvergne, Matthieu Jabaudon highlights the hopeful future for ARDS
